Summary:
- This article discusses the emergence of new weight loss injections, such as Wegovy and Ozempic, and how they are becoming a symbol of wealth and privilege.
- These injections can cost thousands of dollars per year, making them inaccessible to many people struggling with obesity, particularly those from lower-income backgrounds.
- The article highlights the concern that these treatments could further widen the gap between the wealthy and the less fortunate, as access to effective weight loss solutions becomes increasingly dependent on one's financial resources.